Skip to main content

by Mary E. King

 

Photo of Hyman B. Muss, MD

Hyman B. Muss MD is an experienced clinician-scientist, the Mary Jones Hudson Distinguished Professor of Geriatric Oncology at the University of North Carolina School of Medicine, and Geriatric Oncology Program Director at the UNC Lineberger Comprehensive Cancer Center Program.

Some of us are not aware that the United States Army awarded Dr. Muss the Bronze Star medal for his service in Vietnam.

On November 11, 2020, Dr. Muss will speak on “The Aging Cancer Patient Population in North Carolina.” He will discuss the demographics of cancer and aging, the value of a Geriatric Assessment in caring for older patients, and how they use the Geriatric Assessment and other tools to optimize care.

“Something that I want to share about working with an aging population is that they have great stories, and they are worth listening to,” said Dr. Muss.

Dr. Muss has spoken on our series in the past. To see some of Dr. Muss’s previous lectures, click here: “Addressing the Needs of Breast Cancer Patients Ages 70 and Older” and Optimizing Care for the Older Cancer Patient.

 

Photo of Christopher Dittus, DO, MPH

Christopher Dittus, DO, MPH, will speak on November 18, 2020, on “Lymphoma Management in North Carolina: Updates for 2020.

Dr. Dittus specializes in the diagnosis and management of all types of lymphoma, including B-cell non-Hodgkin lymphoma (NHL), T-cell NHL, and Hodgkin lymphoma. He is particularly interested in viral and rare lymphomas, including adult T-cell leukemia/lymphoma (ATLL), extranodal NK/T-cell lymphoma (ENKTCL), plasmablastic lymphoma, primary central nervous system lymphoma (PCNSL), and lymphoplasmacytic lymphoma (Waldenstrom’s). Dr. Dittus is also a clinical researcher and specializes in investigator-initiated clinical trials aimed at rare and underserved lymphomas. He serves as the AIDS Malignancy Consortium (AMC) site PI at UNC.

As a specialist in rare and viral lymphomas, he will be providing updates to the diagnosis and management of some of the rare subtypes of lymphoma. Specifically, he will help the practitioner identify rare lymphomas and develop a general treatment approach, and will assist in how to decide when to refer a patient to a tertiary care center.

To see our entire collection of videos, click here www.unccn.org.

Please note that Free Continuing Education Credits are available.

You will find full details on all upcoming lectures toward the bottom of the newsletter.